Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI001) with apoptosis-inducing mechanisms in breast cancer-Reference-Cited by-同舟云学术

Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI001) with apoptosis-inducing mechanisms in breast cancer

Published:2015-01-27 Issue:9 Volume:6 Page:6762-6775
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Bo¹,Fu Leilei¹,Zhang Cui²,Zhang Lan²,Zhang Yonghui¹³,Ouyang Liang¹,He Gu¹,Huang Jian²

Affiliation:

1. State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China

2. School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China

3. Collaborative Innovation Center for Biotherapy, Department of Pharmacology & Pharmaceutical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Therapeutics in the Pipeline Targeting for Triple-Negative Breast Cancer: Origin, Challenges, Opportunities, and Mechanisms of Action;International Journal of Molecular Sciences;2024-06-06

2. Current Trends in Computational Chemistry for Breast Cancer;Letters in Drug Design & Discovery;2023-01

3. Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer;International Journal of Biological Sciences;2023

4. Targeting Extracellular Signal-Regulated Protein Kinase 1/2 (ERK1/2) in Cancer: An Update on Pharmacological Small-Molecule Inhibitors;Journal of Medicinal Chemistry;2022-10-07

5. Current developments in extracellular-regulated protein kinase (ERK1/2) inhibitors;Drug Discovery Today;2022-05